Motive Health Celebrates a Milestone Year
Motive Health, Inc. has proudly marked its first full year as a direct-to-consumer (DTC) brand for knee pain therapy. This innovative company, known for its cutting-edge neuromuscular electrical stimulation (NMES) technology, has successfully transitioned from offering prescription-only products under the name CyMedica Orthopedics to embracing a model that connects directly with consumers. With over a decade in the healthcare technology field, they have provided effective solutions to more than 25,000 individuals dealing with chronic knee issues.
Transformation into a Consumer Brand
Motive Health was originally conceptualized in 2014 by orthopedic surgeon Dr. Struan Coleman, who recognized a need for accessible knee therapies. After years of research and development, the company received FDA clearance for its NMES device, allowing it to sell directly to consumers without a prescription. This advancement has empowered patients who previously had limited access to such innovative treatments.
Achievements in the First Year
The past year has involved significant growth for Motive Health. The company has successfully expanded its reach to customers in all 50 states and ventured into online retail through platforms such as Amazon. Many users have reported transformative experiences, referring to the treatment as 'game-changing' in their battle against knee pain.
Survey Insights into Joint Pain Awareness
In light of its mission to enhance wellness, Motive recently partnered with Talker Research to conduct a nationwide survey. The results revealed that nearly half of American adults have limited their activities due to joint pain. Furthermore, a significant percentage are eager to incorporate new technologies into their at-home wellness routines. These findings highlight the growing demand and potential for innovative solutions like those offered by Motive.
Testimonials from Users and Leadership
Rob Morocco, the President and CEO of Motive Health, expressed the profound impacts of their technology on users' lives. He noted how the device has helped individuals regain mobility and pursue their passions, from grandparents wishing to play with their grandchildren to avid runners recovering from injuries. This success in the first year has set a strong foundation for further development.
Future Directions for Motive Health
Looking forward, the team at Motive Health is excited to innovate further. They are developing potential enhancements to their product and app to improve user experience and expand its applications. While their primary focus remains on knee pain, they are also considering how their technology can address other types of joint pain across the body.
Product Information and Accessibility
The Motive Knee device, sold by Motive Health, Inc., is competitively priced starting at $249. Each kit provides comprehensive therapy pads tailored for both left and right knees, ensuring maximum effectiveness.
Frequently Asked Questions
What is Motive Health, Inc. known for?
Motive Health, Inc. specializes in neuromuscular electrical stimulation technology aimed at treating knee pain and improving muscle strength.
How does the NMES technology work?
NMES technology uses electrical impulses to stimulate muscles and reduce pain, helping users improve mobility and strength effectively.
Can anyone use the Motive Knee device?
While generally safe for many users, it’s recommended to consult with a healthcare professional before starting any new treatment, especially for those with pre-existing health conditions.
Where can I buy the Motive Knee device?
The Motive Knee device is available for purchase online through Motive Health’s website and on major platforms like Amazon.
What does the kit include?
The kit includes various therapy pads designed to treat both knees effectively, ensuring a comprehensive approach to pain management.
